Mismanagement

CBTCABOT CORP

Miscellaneous Chemical Products

Revenue
$3.7BFY2021: $3.4BFY2022: $4.3BFY2023: $3.9BFY2024: $4.0BFY2025: $3.7B
7.0% YoY
Operating margin
16.7%FY2021: 13.3%FY2022: 9.0%FY2023: 13.4%FY2024: 15.4%FY2025: 16.7%
8.8% YoY
EBITDA
$775MFY2021: $614MFY2022: $535MFY2023: $670MFY2024: $765MFY2025: $775M
1.3% YoY
Market cap
—
Employees
—
Net debt / EBITDA
1.0×
$788M net debt
AI in 10-K
—

Red flags 0 of 9

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$3.4B$4.3B$3.9B$4.0B$3.7B 7.0% FY2021: $3.4BFY2022: $4.3BFY2023: $3.9BFY2024: $4.0BFY2025: $3.7B
Operating income$454M$389M$526M$614M$621M 1.1% FY2021: $454MFY2022: $389MFY2023: $526MFY2024: $614MFY2025: $621M
Net income$250M$209M$445M$380M$331M 13% FY2021: $250MFY2022: $209MFY2023: $445MFY2024: $380MFY2025: $331M
Operating cash flow$257M$100M$595M$692M$665M 3.9% FY2021: $257MFY2022: $100MFY2023: $595MFY2024: $692MFY2025: $665M
Capex$195M$211M$244M$241M$274M 14% FY2021: $195MFY2022: $211MFY2023: $244MFY2024: $241MFY2025: $274M
Stock-based comp$21M$23M$20M$25M$24M 4.0% FY2021: $21MFY2022: $23MFY2023: $20MFY2024: $25MFY2025: $24M
Buybacks$3M$53M$98M$172M$168M 2.3% FY2021: $3MFY2022: $53MFY2023: $98MFY2024: $172MFY2025: $168M
Dividends$80M$84M$88M$93M$96M 3.2% FY2021: $80MFY2022: $84MFY2023: $88MFY2024: $93MFY2025: $96M

Deal filings

None.

13D filers

None on file.

Insider trading

No open-market trades in the last 12 months.

Pay vs performance

No pay-versus-performance disclosure yet.